E. Garon 1, N. Reinmuth 2, L. Falchero 3, Y. García 4, J. Hureaux 5, I. Gore 6, R. Harris 7, P. Bidoli 8, E. Baldini 9, S. Ros 10, E. Laack 11, P. Mitchell 12, M. Wolf 13, K. O’byrne 14, L. Zibdawi 15, K. Jao 16, D. Spigel 17, A. Li 18, S. Rabindran 18, E. Pichon 19, ⁎
1 University of California Los Angeles, California, États-Unis
2 Asklepios Klinik München-Gauting, Munich, Allemagne
3 L’hôpital Nord Ouest, Villefranche-sur-Saône, France
4 Parc Taulí Hospital Universitari, I3PT, UAB, Sabadell, Espagne
5 CH d’Angers, Angers, France
6 Alabama Oncology, Birmingham, AL, États-Unis
7 Broome Oncology, USOR, Johnson City, NY, États-Unis
8 Azienda Socio Sanitaria Territoriale, ASST di Monza, Monza, Italie
9 Oncology Department, Medical Oncology Division, San Luca Hospital, Lucca, Italie
10 Department of Internal Medicine, University of Murcia, Murica, Espagne
11 Hämato-Onkologie Hamburg, Hamburg, Allemagne
12 Austin Health, Victoria, Australie
13 Klinikum Kassel, Hessen, Allemagne
14 Princess Alexandra Hospital, Woolloongabba, Queensland, Australie
15 Southlake Regional Health Centre, Newmarket, Ontario, Canada
16 Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada
17 Sarah Cannon Research Institute, Tennessee Oncology Nashville, PLLC, Nashville, TN, États-Unis
18 Bristol-Myers Squibb Company, Princeton, NJ, États-Unis
19 CHRU de Bretonneau, Tours, France